Your browser doesn't support javascript.
loading
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines.
Zarkavelis, G; Amylidi, A L; Verbaanderd, C; Cherny, N I; Metaxas, Y; de Vries, E G E; Zygoura, P; Amaral, T; Jordan, K; Strijbos, M; Dafni, U; Latino, N; Galotti, M; Lordick, F; Giuliani, R; Pignatti, F; Pentheroudakis, G.
Affiliation
  • Zarkavelis G; University of Ioannina-Department of Medical Oncology, Ioannina, Greece.
  • Amylidi AL; University of Ioannina-Department of Medical Oncology, Ioannina, Greece.
  • Verbaanderd C; European Medicines Agency, Amsterdam, the Netherlands.
  • Cherny NI; Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Metaxas Y; Kantonsspital Münsterlingen, Münsterlingen, Switzerland.
  • de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Zygoura P; Frontier Science Foundation-Hellas, Athens, Greece.
  • Amaral T; Skin Cancer Center, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Jordan K; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany; Department of Hematology, Oncology and Palliative Medicine, Ernst von Bergmann Hospital Potsdam, Potsdam, Germany.
  • Strijbos M; GZA Ziekenhuizen Campus Sint-Augustinus, Antwerp, Belgium.
  • Dafni U; Frontier Science Foundation-Hellas, Athens, Greece; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.
  • Latino N; ESMO Head Office, Lugano, Switzerland.
  • Galotti M; ESMO Head Office, Lugano, Switzerland.
  • Lordick F; Department of Oncology, Gastroenterology, Hepatology, Pulmonology and Infectious Diseases, University Cancer Center Leipzig (UCCL), Leipzig University Medical Center, Leipzig, Germany.
  • Giuliani R; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
  • Pignatti F; European Medicines Agency, Amsterdam, the Netherlands.
  • Pentheroudakis G; ESMO Head Office, Lugano, Switzerland. Electronic address: george.pentheroudakis@esmo.org.
ESMO Open ; 8(1): 100604, 2023 02.
Article in En | MEDLINE | ID: mdl-36870739
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Off-Label Use / Neoplasms Type of study: Prognostic_studies / Qualitative_research Limits: Humans Language: En Journal: ESMO Open Year: 2023 Document type: Article Affiliation country: Grecia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Off-Label Use / Neoplasms Type of study: Prognostic_studies / Qualitative_research Limits: Humans Language: En Journal: ESMO Open Year: 2023 Document type: Article Affiliation country: Grecia Country of publication: Reino Unido